Learn more

Learn more

With the latest economic and business news and insights from Grenoble-Isère

11 Oktober 2017

LXRepair raises 1.1 million euros

LXREPAIR, a start-up specialized in tests to characterize DNA repair, has raised €1.1M in financing from KREAXI, CEA-investissement, XPAND INVESTMENT Ltd (KIS Group), the Grenoble-Savoie-Mont-Blanc Business Angels and private investors. The finances will be used to continue development in France and abroad so as to be able to finalize prospective clinical studies to identify radio-toxicity blood biomarkers (breast and prostate cancer) and tumor-based biomarkers of resistance to radiation and chemotherapy (head and neck cancer).


Another of the company’s major objectives is to industrialize the kits and attain CE-IVD marking for its first test, designed to predict radiotoxicity events, by 2020. LXRepair tests provide a unique and innovative solution for identifying predictive markers of response to cancer therapies based on DNA repair measurement.